1. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438). Issue 7 (July 2016) Authors: Otake, Kazuyoshi; Sakurai, Yuuichi; Nishida, Haruyuki; Fukui, Hideo; Tagawa, Yoshihiko; Yamasaki, Hitomi; Karashima, Masatoshi; Otsuka, Keiichi; Inatomi, Nobuhiro Journal: Advances in therapy Issue: Volume 33:Issue 7(2016) Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK‐272 (SCO‐272), a novel orally active renin inhibitor. (13th March 2018) Authors: Ebihara, Takuya; Nishihara, Mitsuhiro; Takahashi, Junzo; Jinno, Fumihiro; Tagawa, Yoshihiko Journal: Biopharmaceutics & drug disposition Issue: Volume 39:Number 3(2018:Apr.) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs. (4th March 2017) Authors: Kogame, Akifumi; Takeuchi, Toshiyuki; Nonaka, Masami; Yamasaki, Hitomi; Kawaguchi, Naohiro; Bernards, Ai; Tagawa, Yoshihiko; Morohashi, Akio; Kondo, Takahiro; Moriwaki, Toshiya; Asahi, Satoru Journal: Xenobiotica Issue: Volume 47:Number 3(2017) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humans. (3rd April 2019) Authors: Kogame, Akifumi; Lee, Ronald; Pan, Liping; Sudo, Miyako; Nonaka, Masami; Moriya, Yuu; Higuchi, Tomoaki; Tagawa, Yoshihiko Journal: Xenobiotica Issue: Volume 49:Number 4(2019:Apr.) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of low background liquid scintillation counter for non-clinical ADME studies. (June 2013) Authors: Onishi, Akemi; Kogame, Akifumi; Tagawa, Yoshihiko; Kondo, Takahiro; Asahi, Satoru Journal: Xenobiotica Issue: Volume 43:Number 6(2013:Jun.) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of acute fat mobilisation on the pharmacokinetics of the highly fat distributed compound TAK‐357, investigated by physiologically based pharmacokinetic (PBPK) modeling and simulation. (23rd May 2017) Authors: Goto, Akihiko; Tagawa, Yoshihiko; Moriya, Yuu; Sato, Sho; Furukawa, Yoshiyuki; Wakabayashi, Takeshi; Tsukamoto, Tetsuya; DeJongh, Joost; van Steeg, Tamara J.; Moriwaki, Toshiya; Asahi, Satoru Journal: Biopharmaceutics & drug disposition Issue: Volume 38:Number 6(2017:Sep.) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation. (9th November 2017) Authors: Goto, Akihiko; Tagawa, Yoshihiko; Moriya, Yuu; Sato, Sho; Yamamoto, Masami; Wakabayashi, Takeshi; Tsukamoto, Tetsuya; DeJongh, Joost; van Steeg, Tamara J.; Moriwaki, Toshiya; Asahi, Satoru Journal: Biopharmaceutics & drug disposition Issue: Volume 38:Number 9(2017:Dec.) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Influence of the pharmacokinetic profile on the plasma glucose lowering effect of the PPARγ agonist pioglitazone in Wistar fatty rats. (28th May 2017) Authors: Goto, Akihiko; Tagawa, Yoshihiko; Kimura, Yoshiaki; Kogame, Akifumi; Moriya, Yuu; Amano, Nobuyuki Journal: Biopharmaceutics & drug disposition Issue: Volume 38:Number 6(2017:Sep.) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Investigation of disposition for TAK-448, a synthetic peptide of kisspeptin analog, in rats and dogs using the radiolabeled TAK-448 suitable for pharmacokinetic study. (3rd July 2019) Authors: Moriya, Yuu; Kogame, Akifumi; Tagawa, Yoshihiko; Morohashi, Akio; Kondo, Takahiro; Asahi, Satoru Journal: Xenobiotica Issue: Volume 49:Number 7(2019:Jul.) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetic and pharmacodynamic modeling of the metastin/kisspeptin analog, TAK‐448, for its anti‐tumor efficacy in a rat xenograft model. (16th July 2020) Authors: Kogame, Akifumi; Ishikawa, Kaori; DeJongh, Joost; Tagawa, Yoshihiko; Matsui, Hisanori; Moriya, Yuu; Kondo, Takahiro; Asahi, Satoru Journal: Biopharmaceutics & drug disposition Issue: Volume 41:Number 7(2020) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗